Insights

Raymond Cross, MD, director of the Inflammatory Bowel Disease program at the University of Maryland School of Medicine, discussed the positioning and uses of 5-ASAs and corticosteroids in the treatment of patients with inflammatory bowel...

Michele Rubin, APN, of UChicago Medicine, discusses the importance of finding the right drug for each patient as part of the move toward personalized medicine.

Fernando Velayos, MD, codirector of the Crohn's and Colitis program at the University of California-San Francisco Medical Center, argues the case for why immunomodulators should not be used as monotherapy in treating inflammatory bowel...

Gil Melmed, MD, codirector of the Inflammatory Bowel Disease Center at Cedars-Sinai Medical Center in Los Angeles, California, makes the case for using immunomodulators as monotherapy in treating inflammatory bowel disease.

Edward Loftus, MD, professor of medicine at the Mayo Clinic in Rochester, Minnesota, discusses targeted biopsies, endoscopic mucosal resections, and endoscopic mucosal dissection as therapeutic techniques for treating dysplastic and mass...

Gary R Lichtenstein, MD, director of the Center for Inflammatory Bowel Disease at the University of Pennsylania Health System in Philadelphia, talks about choosing the best approaches to ensure optimal performance of chromoendoscopy.